| Pharmaceutical active ingredients: |
| Isosorbide Mononitrate |
| Available forms, composition and doses of Monocedocard: |
| N / A |
| Monocedocard medical category: |
| Human:Anti-anginal drugsNitrates and nitrites |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA14 - Isosorbide Mononitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Monisid | Isosorbide Mononitrate | Unidentified Pharmaceutical Company |
| Monite | Hydroxyapatite | Unidentified Pharmaceutical Company |
| Monizid | Isosorbide Mononitrate | Unidentified Pharmaceutical Company |
| Monobactam | Aztreonam | Unidentified Pharmaceutical Company |
| Monobutyl | Mofebutazone | Unidentified Pharmaceutical Company |
| Monodion | Vitamin K1 (Phytonadione) | Unidentified Pharmaceutical Company |
| Monodorm | Butobarbital | Unidentified Pharmaceutical Company |
| Monofen | Mofebutazone | Unidentified Pharmaceutical Company |
| Monofuracin | Nitrofurazone | Unidentified Pharmaceutical Company |
| Mono-Kay | Vitamin K1 (Phytonadione) | Unidentified Pharmaceutical Company |